Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study

PURPOSE: The role of adjuvant chemoradiotherapy (CRT) in resectable pancreatic cancer is still debated. This randomized phase II intergroup study explores the feasibility and tolerability of a gemcitabine-based CRT regimen after R0 resection of pancreatic head cancer. PATIENTS AND METHODS: Within 8...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Van Laethem, Jean-Luc, Hammel, Pascal, Mornex, Françoise, Azria, David, Van Tienhoven, Geertjan, Vergauwe, Philippe, Peeters, Marc, Polus, Marc, Praet, Michel, Mauer, Murielle, Collette, Laurence, Budach, Volker, Lutz, Manfred, Van Cutsem, Eric, Haustermans, Karin
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2010
Assuntos:
Original Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2988636/
https://ncbi.nlm.nih.gov/pubmed/20837948
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.30.3446
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares